Clinical Trial Excellence

Clinical Endpoints is a Site Management Organization (SMO) that performs proof of concept studies in their entirety to test new therapeutic and imaging agents and develop the critical success pathway for later stage trials. We have also become the top enrolling site globally for many large, late-stage, global trials, including numerous trials in neurological disorders. Due to our thorough understanding of the intricacies involved in conducting clinical trials, we are able to provide continuous support from feasibility to study closeout.

We specialize in providing personalized, concierge-level services to clinical trial patients through world-class health care professionals. We understand the importance of personalized patient services, as well as the hope that promising clinical trial treatments may bring to our physician partners, their patients, and their patient’s families.

At Clinical Endpoints we partner with leading physicians that are motivated to provide new treatments in development as another option for their patients. Our physician partners typically collaborate with us at one of the three levels: Patient referral, Sub-investigator (Sub-I), or Principal investigator (PI).

We are a leading center globally for the most promising and potentially life-saving clinical trial treatments offered by the world’s top-rated pharmaceutical companies. We specialize in offering additional options to patients that have exhausted traditional treatments and now seek new hope.

Clinical Endpoints SMO can manage any therapeutic area. Clinical trials are focused on: